Close Menu

NEW YORK – The US Department of Justice said yesterday that UTC Laboratories, previously known as Renaissance Rx, has agreed to pay $41.6 million to settle allegations that they paid kickbacks for lab referrals for pharmacogenetic testing and for billing for tests that were not medically necessary.

The company also accepted a 25-year ban on participating in any federal healthcare program.

Additionally, company principals Tarun Jolly, Patrick Ridgeway, and Barry Griffith agreed to pay $1 million to resolve the allegations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.